Current stage?-Stage I - Page 24 of 24 Posts on Medivizor
Navigation Menu

Current stage?-Stage I Posts on Medivizor

Standard Chemotherapy versus Capecitabine (Xeloda) in Older Women with Early-Stage Breast Cancer

Standard Chemotherapy versus Capecitabine (Xeloda) in Older Women with Early-Stage Breast Cancer

Posted by on Feb 24, 2013 in Breast cancer | 0 comments

In a nutshell This trial compared standard chemotherapy regimens and Capecitabine (Xeloda) in women over 65 years old. The main outcome was that standard chemotherapy worked better in this age group. Some background Capecitabine is generally used in breast cancer resistant to other chemotherapy. It is also the first approved treatment that can be...

Read More

Detecting cancer cells in the blood stream as means to predict recurrence

Detecting cancer cells in the blood stream as means to predict recurrence

Posted by on Feb 24, 2013 in Breast cancer | 0 comments

In a nutshell The present study evaluated whether the presence of cancer cells in the blood stream predicts a worse prognosis in women with operable breast cancer. The main finding was that progression-free survival (time before cancer progression) and overall survival were lower if circulating cancer cells were detected in the blood. Some background...

Read More

Focal Ultrasound-based therapy for prostate cancer as means to reduced genito-urinary side effects

Focal Ultrasound-based therapy for prostate cancer as means to reduced genito-urinary side effects

Posted by on Feb 24, 2013 in Prostate cancer | 0 comments

In a nutshell This study evaluated whether focal Ultrasound-based therapy of individual cancer lesions can minimize the side effects associated with radical therapy that involves the whole prostate gland. Main findings: Focused therapy directed into cancer tissues significantly reduces genitourinary side effects like urine-leakage and impotence. Some...

Read More

New hormonal therapy protocol of for patients with rising PSA after radiotherapy

New hormonal therapy protocol of for patients with rising PSA after radiotherapy

Posted by on Feb 24, 2013 in Prostate cancer | 0 comments

In a nutshell This study compared intermittent versus continuous androgen deprivation therapy (ADT) for localized (confined) prostate cancer due to prostate-specific antigen (PSA) elevation after radiotherapy. Main findings: Intermittent ADT was not inferior compared to continuous therapy with respect to survival. However, some quality of life...

Read More

A new biomarker panel for the assessment of prostate cancer recurrence risk

A new biomarker panel for the assessment of prostate cancer recurrence risk

Posted by on Feb 24, 2013 in Prostate cancer | 0 comments

In a nutshell The present study evaluated a new biomarker that could be used to predict recurrence of prostate cancer after surgical removal of the prostate gland (prostatectomy). Three proteins called Sp1/Sp3/FLIP, combined with the Gleason score were found highly prognostic in the prediction of recurrence, and can therefore help guiding the initial...

Read More

Isolated cancer cells in lymph nodes increase the risk of the cancer re-occurring after surgery: A method to detect these isolated cells

Isolated cancer cells in lymph nodes increase the risk of the cancer re-occurring after surgery: A method to detect these isolated cells

Posted by on Feb 24, 2013 in Colorectal cancer | 0 comments

Colorectal cancer is the uncontrolled growth of cells in the rectum, colon (the large intestine) and it can also affect the appendix. It affects both men and women. Patients who are diagnosed with stage 1 and 2 colorectal cancer (cancers affecting the lining of the intestines – stage 1, and the muscle wall – stage 2) are generally only...

Read More